Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

被引：72
作者：
Lemieux, B [1 ]
Tartas, S [1 ]
Traulle, C [1 ]
Espinouse, D [1 ]
Thieblemont, C [1 ]
Bouafia, F [1 ]
Alhusein, Q [1 ]
Antal, D [1 ]
Salles, G [1 ]
Coiffier, B [1 ]
机构：
[1] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Haematol, F-69495 Pierre Benite, France
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 09期
关键词：
non-Hodgkin's lymphoma; rituximab; autologous transplantation;
D O I：
10.1038/sj.bmt.1704467
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.
引用
收藏
页码：921 / 923
页数：3
相关论文
共 50 条
[41]   The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma [J].
Yoong, Y ;
Porrata, LF ;
Inwards, DJ ;
Ansell, SM ;
Micallef, INM ;
Litzow, MR ;
Gertz, MA ;
Lacy, MQ ;
Dispenzieri, A ;
Gastineau, DA ;
Tefferi, A ;
Elliott, M ;
Snow, DS ;
Hogan, WJ ;
Markovic, SN .
LEUKEMIA & LYMPHOMA, 2005, 46 (09) :1287-1294
[42]   Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma [J].
M Takeuchi ;
A Tamaoki ;
A Tada ;
Y Jyo ;
S Nomura ;
K Takahashi ;
G Ohsawa ;
M Kibata .
Bone Marrow Transplantation, 1998, 22 :725-727
[43]   What Is the Role of Stem-Cell Transplantation for Follicular Non-Hodgkin Lymphoma in the Rituximab Era? [J].
Schouten, Harry C. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) :1617-1618
[44]   Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma [J].
Milojkovic, D ;
Mijovic, A ;
Taylor, CG ;
Mufti, GJ ;
Pagliuca, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) :1013-1014
[45]   Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma [J].
Kewalramani, T ;
Nimer, SD ;
Zelenetz, AD ;
Malhotra, S ;
Qin, J ;
Yahalom, J ;
Moskowitz, CH .
BONE MARROW TRANSPLANTATION, 2003, 32 (07) :673-679
[46]   Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma [J].
T Kewalramani ;
S D Nimer ;
A D Zelenetz ;
S Malhotra ;
J Qin ;
J Yahalom ;
C H Moskowitz .
Bone Marrow Transplantation, 2003, 32 :673-679
[47]   Stem-cell transplantation in non-Hodgkin's lymphoma:: improving outcome [J].
Gianni, AM ;
Berinstein, NL ;
Evans, PAS ;
López-Guillermo, A ;
Solano, C .
ANTI-CANCER DRUGS, 2002, 13 :S35-S42
[48]   High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin's lymphoma in the rituximab era [J].
Garcia Escobar, Ignacio ;
Cantos Sanchez de Ibargueen, Blanca ;
Calvo de Juan, Virginia ;
Maximiano Alonso, C. ;
Mendez Garcia, Miriam ;
Sanchez Ruiz, Antonio Carlos ;
Provencio Pulla, Mariano .
TUMORI JOURNAL, 2015, 101 (01) :2-7
[49]   Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma [J].
Graf, S. A. ;
Stevenson, P. A. ;
Holmberg, L. A. ;
Till, B. G. ;
Press, O. W. ;
Chauncey, T. R. ;
Smith, S. D. ;
Philip, M. ;
Orozco, J. J. ;
Shustov, A. R. ;
Green, D. J. ;
Libby, E. N., III ;
Bensinger, W. I. ;
Pagel, J. M. ;
Maloney, D. G. ;
Zhou, Y. ;
Cassaday, R. D. ;
Gopal, A. K. .
ANNALS OF ONCOLOGY, 2015, 26 (11) :2323-2328
[50]   Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma [J].
Rothe, A ;
Schulz, H ;
Elter, T ;
Engert, A ;
Reiser, M .
HAEMATOLOGICA, 2004, 89 (07) :875-876
12345